A detailed history of Td Asset Management Inc transactions in Verona Pharma PLC stock. As of the latest transaction made, Td Asset Management Inc holds 225,582 shares of VRNA stock, worth $24.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
225,582
Previous 229,742 1.81%
Holding current value
$24.1 Million
Previous $14.6 Million 46.27%
% of portfolio
0.02%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 28, 2025

SELL
$53.9 - $98.68 $224,224 - $410,508
-4,160 Reduced 1.81%
225,582 $21.3 Million
Q1 2025

May 07, 2025

SELL
$44.81 - $69.63 $426,591 - $662,877
-9,520 Reduced 3.98%
229,742 $14.6 Million
Q4 2024

Feb 11, 2025

BUY
$28.71 - $47.02 $1.82 Million - $2.97 Million
63,262 Added 35.94%
239,262 $11.1 Million
Q3 2024

Nov 01, 2024

BUY
$15.46 - $30.16 $841,024 - $1.64 Million
54,400 Added 44.74%
176,000 $5.06 Million
Q2 2024

Aug 02, 2024

BUY
$11.48 - $17.02 $1.4 Million - $2.07 Million
121,600 New
121,600 $1.76 Million

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $6.51B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.